Ben Fidler's articles Biotechnology Roche says it’ll move quickly with ‘differentiated’ obesity drugs CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect. Written by Ben Fidler July 26, 2024July 26, 2024 Saving Bookmark this article Bookmarked Biotechnology Duchenne approval exposes FDA rift over Sarepta gene therapy Peter Marks’ decision to override the objections of agency staff and broaden use of Elevidys could have a “lasting impact” on gene therapy as well as the FDA, one analyst wrote. Written by Ben Fidler June 22, 2024June 22, 2024 Saving Bookmark this article Bookmarked
Biotechnology Roche says it’ll move quickly with ‘differentiated’ obesity drugs CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect. Written by Ben Fidler July 26, 2024July 26, 2024 Saving Bookmark this article Bookmarked
Biotechnology Duchenne approval exposes FDA rift over Sarepta gene therapy Peter Marks’ decision to override the objections of agency staff and broaden use of Elevidys could have a “lasting impact” on gene therapy as well as the FDA, one analyst wrote. Written by Ben Fidler June 22, 2024June 22, 2024 Saving Bookmark this article Bookmarked
